vx 497 has been researched along with odanacatib in 1 studies
Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (odanacatib) | Trials (odanacatib) | Recent Studies (post-2010) (odanacatib) |
---|---|---|---|---|---|
25 | 3 | 7 | 148 | 27 | 128 |
Protein | Taxonomy | vx 497 (IC50) | odanacatib (IC50) |
---|---|---|---|
Cathepsin L2 | Homo sapiens (human) | 0.762 | |
Procathepsin L | Homo sapiens (human) | 3.919 | |
Cathepsin B | Homo sapiens (human) | 1.3613 | |
Cathepsin S | Homo sapiens (human) | 0.197 | |
Cathepsin K | Homo sapiens (human) | 0.0005 | |
Cathepsin K | Oryctolagus cuniculus (rabbit) | 0.001 | |
Cathepsin F | Homo sapiens (human) | 0.795 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and odanacatib
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |